Advertisement

Hypothermic Machine Perfusion in Liver Transplantation Using Grafts From Donation After Circulatory Death Donors

  • Andrea Schlegel
  • Matteo Mueller
  • Philipp DutkowskiEmail author
Chapter
  • 14 Downloads

Abstract

Dynamic preservation strategies are a promising option to improve graft quality and to extend preservation time for either logistic or treatment reasons. In contrast to normothermic oxygenated perfusion, which is based on physiologic conditions, thereby aiming to simulate the human body, hypothermic oxygenated liver perfusion appears un-physiologic and induces a unique, mitochondrial response for its protective effect. Both ex vivo perfusion techniques can be used for viability assessment, which will open the door for an increased liver utilization in the future.

Keywords

Oxidative injury Mitochondria Viability 

References

  1. 1.
    Abele D, et al. Temperature-dependence of mitochondrial function and production of reactive oxygen species in the intertidal mud clam Mya Mya arenaria. J Exp Biol. 2002;11:1636.  https://doi.org/10.1016/j.ecolind.2011.04.007.CrossRefGoogle Scholar
  2. 2.
    Abele D. Toxic oxygen: the radical life-giver. Nature. 2002;420:27.  https://doi.org/10.1038/420027a.CrossRefPubMedGoogle Scholar
  3. 3.
    Blier PU, et al. What modulates animal longevity? Fast and slow aging in bivalves as a model for the study of lifespan. Semin Cell Dev Biol. 2017;70:130.  https://doi.org/10.1016/j.semcdb.2017.07.046.CrossRefPubMedGoogle Scholar
  4. 4.
    Boteon Y, et al. Combined hypothermic and normothermic machine perfusion improves functional recovery of extended criteria donor livers. Liver Transpl. 2018;24:1699–715.  https://doi.org/10.1002/lt.25315.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Brüggenwirth IMA, et al. A comparative study of single and dual perfusion during end-ischemic subnormothermic liver machine preservation. Transplant Direct. 2018;4:e400.  https://doi.org/10.1097/TXD.0000000000000840.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Bruinsma BG, et al. Determination and extension of the limits to static cold storage using subnormothermic machine perfusion. Int J Artif Organs. 2013;36(11):775–80.  https://doi.org/10.5301/ijao.5000250.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Bruinsma BG, et al. Subnormothermic machine perfusion for ex vivo preservation and recovery of the human liver for transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14(6):1400–9.  https://doi.org/10.1111/ajt.12727.CrossRefGoogle Scholar
  8. 8.
    Burlage L, et al. Opposite acute potassium and sodium shifts during transplantation of hypothermic machine perfused donor livers. Am J Transplant. 2018;19:1061.  https://doi.org/10.1111/ajt.15173.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Croome KP, Lee DD, Keaveny AP, Taner CB. Noneligible donors as a strategy to decrease the organ shortage. Am J Transplant. 2017;17(6):1649–55.CrossRefGoogle Scholar
  10. 10.
    De Carlis L, et al. Sequential use of normothermic regional perfusion and hypothermic machine perfusion in donation after cardiac death liver transplantation with extended warm ischemia time. Transplantation. 2016;100:e101.  https://doi.org/10.1097/TP.0000000000001419.CrossRefPubMedGoogle Scholar
  11. 11.
    De Carlis R, et al. Hypothermic machine perfusion of liver grafts can safely extend cold ischemia for up to 20 hours in cases of necessity. Transplantation. 2017;101:e223–4.  https://doi.org/10.1097/TP.0000000000001753.CrossRefPubMedGoogle Scholar
  12. 12.
    De Carlis R, et al. Successful donation after cardiac death liver transplants with prolonged warm ischemia time using normothermic regional perfusion. Liver Transpl. 2017;23:166.  https://doi.org/10.1002/lt.24666.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    De Carlis R, et al. Donation after cardiac death liver transplantation with normothermic regional perfusion and hypothermic machine perfusion: follow-up of the first Italian series. Portugal: ILTS Conference Lisbon; 2018.Google Scholar
  14. 14.
    Chouchani ET, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515(V):431–5.  https://doi.org/10.1038/nature13909.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Chouchani ET, et al. A unifying mechanism for mitochondrial superoxide production during ischemia-reperfusion injury. Cell Metabolism. 2016;23:254–63.  https://doi.org/10.1016/j.cmet.2015.12.009.CrossRefPubMedGoogle Scholar
  16. 16.
    Detelich D, Markmann JF. The dawn of liver perfusion machines. Curr Opin Organ Transplant. 2018;23:151.  https://doi.org/10.1097/MOT.0000000000000500.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Dufour S, et al. Top-down control analysis of temperature effect on oxidative phosphorylation. Biochem J. 1996;314:743.  https://doi.org/10.1042/bj3140743.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Dugbartey GJ, et al. Renal mitochondrial response to low temperature in non-hibernating and hibernating species. Antioxid Redox Signal. 2017;27:599.  https://doi.org/10.1089/ars.2016.6705.CrossRefPubMedGoogle Scholar
  19. 19.
    Dutkowski P, Clavien P. Uploading cellular batteries: caring for mitochondria is key. Liver Transpl. 2018;24(4):462–4.  https://doi.org/10.1002/lt.25036.CrossRefPubMedGoogle Scholar
  20. 20.
    European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL clinical practice guidelines: liver transplantation. J Hepatol. 2016;64(2):433–85.CrossRefGoogle Scholar
  21. 21.
    Gringeri E, et al. Subnormothermic machine perfusion for non-heart-beating donor liver grafts preservation in a swine model: a new strategy to increase the donor pool? Transplant Proc. 2012;4:2026–8.  https://doi.org/10.1016/j.transproceed.2012.06.014.CrossRefGoogle Scholar
  22. 22.
    Hashimoto K, et al. Soluble adhesion molecules during ex vivo lung perfusion are associated with posttransplant primary graft dysfunction. Am J Transplant. 2017;17(5):1396–404.  https://doi.org/10.1111/ajt.14160.CrossRefPubMedGoogle Scholar
  23. 23.
    He X, et al. The first case of ischemia-free organ transplantation in humans: a proof of concept. Am J Transplant. 2018;18(3):737–44.  https://doi.org/10.1111/ajt.14583.CrossRefPubMedGoogle Scholar
  24. 24.
    Hessheimer A, et al. Superior outcomes using normothermic regional perfusion in cDCD liver transplantation. Portugal: ILTS Conference Lisbon; 2018.Google Scholar
  25. 25.
    Hosgood SA, et al. Haemoadsorption reduces the inflammatory response and improves blood flow during ex vivo renal perfusion in an experimental model. J Transl Med. 2017;15(1):216.  https://doi.org/10.1186/s12967-017-1314-5.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Iskender I, et al. Cytokine filtration modulates pulmonary metabolism and edema formation during ex vivo lung perfusion [Abstract]. J Heart Lung Transplant. 2016;35(4):S142–3. https://www.jhltonline.org/article/S1053-2498(16)00441-1/fulltext.
  27. 27.
    Kaltenbach M, et al. Trends in deceased donor liver enzymes prior to transplant: the impact on graft selection and outcomes. Am J Transplant. 2019;20:213.  https://doi.org/10.1111/ajt.15573.CrossRefPubMedGoogle Scholar
  28. 28.
    Karki R, Man SM, Kanneganti T-D. Inflammasomes and cancer. Cancer Immunol Res. 2017;5:94.  https://doi.org/10.1158/2326-6066.CIR-16-0269.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Kim M, et al. Attenuation of oxidative damage by targeting mitochondrial complex I in neonatal hypoxic-ischemic brain injury. Free Radic Biol Med. 2018;124:517.  https://doi.org/10.1016/j.freeradbiomed.2018.06.040.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Kron P, et al. Short, cool, and well oxygenated – HOPE for kidney transplantation in a rodent model. Ann Surg. 2016;264:815.  https://doi.org/10.1097/SLA.0000000000001766.CrossRefPubMedGoogle Scholar
  31. 31.
    Kron P, et al. Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans. J Hepatol. 2018;68(1):82–91.  https://doi.org/10.1016/j.jhep.2017.08.028.CrossRefGoogle Scholar
  32. 32.
    Land WG. Emerging role of innate immunity in organ transplantation. Part I: evolution of innate immunity and oxidative allograft injury. Transplant Rev. 2012;26:60–72.  https://doi.org/10.1016/j.trre.2011.05.001.CrossRefGoogle Scholar
  33. 33.
    MacDonald JA, Storey KB. cAMP-dependent protein kinase from brown adipose tissue: temperature effects on kinetic properties and enzyme role in hibernating ground squirrels. J Comp Physiol. 1998;168:513.  https://doi.org/10.1007/s003600050172.CrossRefGoogle Scholar
  34. 34.
    Marcon F, et al. Utilisation of declined liver grafts yields comparable transplant outcomes and previous decline should not be a deterrent to graft use. Transplantation. 2018;  https://doi.org/10.1097/TP.0000000000002127.
  35. 35.
    Matton APM, et al. Biliary bicarbonate, pH, and glucose are suitable biomarkers of biliary viability during ex situ normothermic machine perfusion of human donor livers. Transplantation. 2019;103:1405.  https://doi.org/10.1097/TP.0000000000002500.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    De Meijer V, Fujiyoshi M, Porte R. Ex situ machine perfusion strategies in liver transplantation. J Hepatol. 2018;70:203.  https://doi.org/10.1016/j.jhep.2018.09.019.CrossRefPubMedGoogle Scholar
  37. 37.
    Mergental H, et al. Transplantation of declined liver allografts following normothermic ex-situ evaluation. Am J Transplant. 2016;16(11):3235–45.  https://doi.org/10.1111/ajt.13875.CrossRefPubMedGoogle Scholar
  38. 38.
    Mergental H. et al. Transplantation of discarded livers following viability testing with normothermic machine perfusion: the VITTAL (VIability Testing and Transplantation of mArginal Livers) trial outcomes’, AASLD 2018, Abstract. 2018.Google Scholar
  39. 39.
    Michel SG, et al. Twelve-hour hypothermic machine perfusion for donor heart preservation leads to improved ultrastructural characteristics compared to conventional cold storage. Ann Transplant. 2015;20:461–8.  https://doi.org/10.12659/AOT.893784.CrossRefPubMedGoogle Scholar
  40. 40.
    Mills EL, et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell. 2016;167(2):457–470.e13.  https://doi.org/10.1016/j.cell.2016.08.064.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Minor T, et al. Controlled oxygenated rewarming of cold stored liver grafts by thermally graduated machine perfusion prior to reperfusion. Am J Transplant. 2013;13(6):1450–60.  https://doi.org/10.1111/ajt.12235.CrossRefPubMedGoogle Scholar
  42. 42.
    Muller X, et al. Defining benchmarks in liver transplantation: a multicenter outcome analysis determining best achievable results. Ann Surg. 2017;267(3):419–25.  https://doi.org/10.1097/SLA.0000000000002477.CrossRefGoogle Scholar
  43. 43.
    Muller X, et al. Novel real time prediction of liver graft function during hypothermic oxygenated machine perfusion prior to liver transplantation. Ann Surg. 2019;270(5):783–90.CrossRefGoogle Scholar
  44. 44.
    Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417(1):1–13.  https://doi.org/10.1042/BJ20081386.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Nasralla D, et al. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018;557:50.  https://doi.org/10.1038/s41586-018-0047-9.CrossRefGoogle Scholar
  46. 46.
    Patrono D, et al. Hypothermic Oxygenated Machine Perfusion of Liver Grafts from Brain-Dead Donors. Sci Rep. 2019;9(1):1.  https://doi.org/10.1038/s41598-019-45843-3.CrossRefGoogle Scholar
  47. 47.
    Pinto C, et al. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology. Biochim Biophys Acta Mol basis Dis. 2017;1864:1270.  https://doi.org/10.1016/j.bbadis.2017.07.024.CrossRefPubMedGoogle Scholar
  48. 48.
    Van Rijn R, et al. Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death. Br J Surg. 2017;104:907–17.  https://doi.org/10.1002/bjs.10515.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Schlegel A, et al. Protective mechanisms of end-ischemic cold machine perfusion in DCD liver grafts. J Hepatol. 2013;58(2):278–86.CrossRefGoogle Scholar
  50. 50.
    Schlegel A, et al. Warm vs. cold perfusion techniques to rescue rodent liver grafts. J Hepatol. Elsevier. 2014;61(6):1267–75.CrossRefGoogle Scholar
  51. 51.
    Schlegel A, et al. Warm vs. cold perfusion techniques to rescue rodent liver grafts. J Hepatol. 2014;61(6):1267–75.  https://doi.org/10.1016/j.jhep.2014.07.023.CrossRefPubMedGoogle Scholar
  52. 52.
    Schlegel A, et al. Is single portal vein approach sufficient for hypothermic machine perfusion of DCD liver grafts? J Hepatol. Elsevier. 2016;64:239–41.CrossRefGoogle Scholar
  53. 53.
    Schlegel A, et al. Impact of donor age in donation after cardiac death liver transplantation: Is the cut-off “60” still of relevance? Liver Transplantation. 2017;  https://doi.org/10.1002/lt.24865. [Epub ahead of print].
  54. 54.
    Schlegel A, et al. The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation. J Hepatol. 2018c;68(3):456–64.  https://doi.org/10.1016/j.jhep.2017.10.034.CrossRefGoogle Scholar
  55. 55.
    Schlegel AA, et al. Outcomes of liver transplantations from donation after circulatory death (DCD) treated by hypothermic oxygenated perfusion (HOPE) before implantation. J Hepatol. 2019;70(1):50–7.  https://doi.org/10.1016/j.jhep.2018.10.005.CrossRefPubMedGoogle Scholar
  56. 56.
    Schlegel A, Kalisvaart M, Muiesan P. Machine perfusion in liver transplantation - an essential treatment or just an expensive toy? Minerva Anestesiol. 2018;84(2):236–45.  https://doi.org/10.23736/S0375-9393.17.12016-X.CrossRefPubMedGoogle Scholar
  57. 57.
    Schlegel A, Muller X, Dutkowski P. Hypothermic liver perfusion. Curr Opin Organ Transplant. 2017;22:563.CrossRefGoogle Scholar
  58. 58.
    Schlegel A, Muller X, Dutkowski P. Hypothermic machine preservation of the liver: state of the art. Current Transpl Rep. 2018;5:93.  https://doi.org/10.1007/s40472-018-0183-z.CrossRefGoogle Scholar
  59. 59.
    Selten J, et al. Hypo- and normothermic perfusion of the liver: which way to go? Best Pract Res Clin Gastroenterol. 2017;31:171–9.  https://doi.org/10.1016/j.bpg.2017.04.001.CrossRefPubMedGoogle Scholar
  60. 60.
    Siebels I, Dröse S. Q-site inhibitor induced ROS production of mitochondrial complex II is attenuated by TCA cycle dicarboxylates. Biochim Biophys Acta Bioenerg. 2013;1827(10):1156–64.  https://doi.org/10.1016/j.bbabio.2013.06.005.CrossRefGoogle Scholar
  61. 61.
    Stegemann J, Minor T. Energy charge restoration, mitochondrial protection and reversal of preservation induced liver injury by hypothermic oxygenation prior to reperfusion. Cryobiology. 2009;58(3):331–6.  https://doi.org/10.1016/j.cryobiol.2009.03.003.CrossRefPubMedGoogle Scholar
  62. 62.
    Stepanova A, et al. Redox-Dependent Loss of Flavin by Mitochondrial Complex I in Brain Ischemia/Reperfusion Injury. Antioxid Redox Signal. 2019;31(9):608–22.  https://doi.org/10.1089/ars.2018.7693. Epub 2019 Jul 1.CrossRefPubMedGoogle Scholar
  63. 63.
    Takakuwa Y, et al. Properties and kinetics of membrane-bound enzymes when both the enzyme and substrate are components of the same microsomal membrane. Studies on lathosterol 5-desaturase. J Biol Chem. 1994;269(45):27889–93.  https://doi.org/10.1074/jbc.270.8.4180.CrossRefPubMedGoogle Scholar
  64. 64.
    de Vries Y, et al. Pretransplant sequential hypo- and normothermic machine perfusion of suboptimal livers donated after circulatory death using a hemoglobin-based oxygen carrier perfusion solution. Am J Transplant. 2019;19:1202.  https://doi.org/10.1111/ajt.15228.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Wang CH, et al. Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Exp Biol Med. 2013;238:450.  https://doi.org/10.1177/1535370213493069.CrossRefGoogle Scholar
  66. 66.
    Watson C, et al. Normothermic regional perfusion (NRP) for DCD liver transplantation in the UK: better graft survival with no cholangiopathy. Portugal: ILTS Conference Lisbon; 2018.Google Scholar
  67. 67.
    Watson CJE, et al. Observations on the ex situ perfusion of livers for transplantation. Am J Transplant. 2018;18:2005.  https://doi.org/10.1111/ajt.14687.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Watson CJE, et al. Normothermic perfusion in the assessment and preservation of declined livers before transplantation: Hyperoxia and vasoplegia-important lessons from the first 12 cases. Transplantation. 2017;101:1084.  https://doi.org/10.1097/TP.0000000000001661.CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Watson CJE, Jochmans I. From “gut feeling” to objectivity: machine preservation of the liver as a tool to assess organ viability. Curr Transpl Rep. 2018;5:72.  https://doi.org/10.1007/s40472-018-0178-9.CrossRefPubMedGoogle Scholar
  70. 70.
    Westerkamp A, et al. Oxygenated hypothermic machine perfusion after static cold storage improves hepatobiliary function of extended criteria donor livers. Transplantation. 2016;100(4):825–35.  https://doi.org/10.1097/TP.0000000000001081.CrossRefPubMedGoogle Scholar
  71. 71.
    Westerkamp AC, et al. End-ischemic machine perfusion reduces bile duct injury in donation after circulatory death rat donor livers independent of the machine perfusion temperature. Liver Transpl. 2015;21(10):1300–11.  https://doi.org/10.1002/lt.24200.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Andrea Schlegel
    • 1
  • Matteo Mueller
    • 2
  • Philipp Dutkowski
    • 2
    Email author
  1. 1.Liver UnitQueen Elizabeth Hospital BirminghamBirminghamUK
  2. 2.Department of Surgery and TransplantationUniversity Hospital ZurichZurichSwitzerland

Personalised recommendations